Dosimetric comparison of VitalBeam
®
and Halcyon
TM
2.0 for hypofractionated VMAT with simultaneous integrated boost treatment of early‐stage left‐sided breast cancer
Keyword(s):
2010 ◽
Vol 78
(3)
◽
pp. S827-S828
2009 ◽
Vol 75
(3)
◽
pp. S204
2010 ◽
Vol 94
(3)
◽
pp. 300-306
◽